한글목차

심장 펌프 시장 : 조사 범위

TMR사의 조사 보고서 「세계 심장 펌프 시장」은 2023년부터 2031년까지의 예측 기간에 있어서 시장 지표에 관한 귀중한 인사이트을 얻기 위해, 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사해 있습니다. 2023년 기준년, 2031년 예측년으로 2017년부터 2031년까지 세계 심장펌프 시장의 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 세계 심장 펌프 시장의 복합 연간 성장률(CAGR)도 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 심장 펌프 시장을 파악했습니다.

이 보고서는 세계 심장 펌프 시장 경쟁 구도에 대해 파악하고 있습니다. 세계 심장 펌프 시장에서 사업을 전개하는 주요 기업이 확인되고 각 기업은 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 시장 개척, SWOT는 이 보고서에 소개된 심장 펌프 시장에서 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약: 시장

제4장 시장 개요

• 소개
• 시장 개요
• 시장 역학
• 시장 분석과 예측(2017년-2031년)

제5장 주요 인사이트

• 파이프라인 분석
• 주요 제품/브랜드 분석
• 주요 M&A
• COVID-19 팬데믹의 산업에 대한 영향

제6장 시장 분석과 예측 : 제품별

• 소개 및 정의
• 주요 조사 결과/발전
• 시장 매출 예측 : 제품별(2017년-2031년)
  • IABP
  • VAD
    • LVAD
    • RVAD
    • BVAD
    • 기타
  • TAH
• 시장 매력도 : 제품별

제7장 시장 분석과 예측 : 플로우 레짐별

• 소개 및 정의
• 주요 조사 결과/발전
• 시장 매출 예측 : 플로우 레짐별(2017년-2031년)
  • CFP
  • AFP
  • MFP
• 시장 매력도 : 플로우 레짐별

제8장 시장 분석과 예측 : 치료법별

• 소개 및 정의
• 주요 조사 결과/발전
• 시장 매출 예측 : 치료법별(2017년-2031년)
  • BTC
  • BTT
• 시장 매력도 : 치료법별

제9장 시장 분석과 예측 : 장소별

• 소개 및 정의
• 주요 조사 결과/발전
• 시장 매출 예측 :장소별(2017년-2031년)
  • 이식형
  • 체외식
• 시장 매력도 : 장소별

제10장 시장 분석과 예측 : 최종 사용자별

• 소개 및 정의
• 주요 조사 결과/발전
• 시장 매출 예측 : 최종 사용자별(2017년-2031년)
  • 병원
  • 외래수술센터(ASC)
  • 전문 클리닉
  • 기타
• 시장 매력도 : 최종사용자별

제11장 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 :지역별(2017년-2031년)
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력도 : 지역별

제12장 북미 시장 분석과 예측

제13장 유럽 시장 분석과 예측

제14장 아시아태평양 시장 분석과 예측

제15장 라틴아메리카 시장 분석과 예측

제16장 중동 및 아프리카 시장 분석과 예측

제17장 경쟁 구도

• 시장 경쟁 매트릭스(기업 계층별,기업 규모별)
• 시장 점유율 분석 : 기업별(2022년)
• 기업 프로파일
  • SynCardia Systems, LLC
  • Berlin Heart GmbH
  • Jarvik Heart Inc.
  • Calon Cardio-Technology Ltd.
  • Teleflex Incorporated
  • Abbott Laboratories
  • Medtronic plc

영문목차

Heart Pumps Market - Scope of Report

TMR's report on the global heart pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global heart pumps market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global heart pumps market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the heart pumps market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global heart pumps market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global heart pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global heart pumps market.

The report delves into the competitive landscape of the global heart pumps market. Key players operating in the global heart pumps market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global heart pumps market profiled in this report.

Key Questions Answered in Global heart pumps Market Report:

• What is the sales/revenue generated by heart pumps across all regions during the forecast period?
• What are the opportunities in the global heart pumps market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Heart Pumps Market - Research Objectives and Research Approach

The comprehensive report on the global heart pumps market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global heart pumps market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global heart pumps market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heart Pumps Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Heart Pumps Market Analysis and Forecast, 2017-2031

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Key Product/Brand Analysis
• 5.3. Key Mergers & Acquisitions
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Heart Pumps Market Analysis and Forecast, by Product

• 6.1. Introduction and Definitions
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Intra-aortic Balloon Pumps
  • 6.3.2. Ventricular Assist Devices
    • 6.3.2.1. Left Ventricle Assist Devices (LVAD)
    • 6.3.2.2. Right Ventricle Assist Devices (RVAD)
    • 6.3.2.3. Biventricular Assist Devices (BVAD)
    • 6.3.2.4. Others
  • 6.3.3. Total Artificial Heart
• 6.4. Market Attractiveness, by Product

7. Global Heart Pumps Market Analysis and Forecast, by Flow Regime

• 7.1. Introduction and Definitions
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Flow Regime, 2017-2031
  • 7.3.1. Centrifugal Flow Pump (CFP)
  • 7.3.2. Axial Flow Pump (AFP)
  • 7.3.3. Mixed Flow Pump (MFP)
• 7.4. Market Attractiveness, by Flow Regime

8. Global Heart Pumps Market Analysis and Forecast, By Therapy

• 8.1. Introduction and Definitions
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, By Therapy, 2017-2031
  • 8.3.1. Bridge-to-Candidacy (BTC)
  • 8.3.2. Bridge-to-Transplant (BTT)
• 8.4. Market Attractiveness, By Therapy

9. Global Heart Pumps Market Analysis and Forecast, by Location

• 9.1. Introduction and Definitions
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by Location, 2017-2031
  • 9.3.1. Implantable Heart Pump Devices
  • 9.3.2. Extracorporeal Heart Pump Devices
• 9.4. Market Attractiveness, by Location

10. Global Heart Pumps Market Analysis and Forecast, by End-user

• 10.1. Introduction and Definitions
• 10.2. Key Findings/Developments
• 10.3. Market Value Forecast, by End-user, 2017-2031
  • 10.3.1. Hospitals
  • 10.3.2. Ambulatory Surgical Centers
  • 10.3.3. Specialty Clinics
  • 10.3.4. Others
• 10.4. Market Attractiveness, by End-user

11. Global Heart Pumps Market Analysis and Forecast, by Region

• 11.1. Key Findings
• 11.2. Market Value Forecast, by Region, 2017-2031
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness, by Region

12. North America Heart Pumps Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Intra-aortic Balloon Pumps
  • 12.2.2. Ventricular Assist Devices
    • 12.2.2.1. Left Ventricle Assist Devices (LVAD)
    • 12.2.2.2. Right Ventricle Assist Devices (RVAD)
    • 12.2.2.3. Biventricular Assist Devices (BVAD)
    • 12.2.2.4. Others
  • 12.2.3. Total Artificial Heart
• 12.3. Market Attractiveness, by Product
• 12.4. Market Value Forecast, by Flow Regime, 2017-2031
  • 12.4.1. Centrifugal Flow Pump (CFP)
  • 12.4.2. Axial Flow Pump (AFP)
  • 12.4.3. Mixed Flow Pump (MFP)
• 12.5. Market Attractiveness, by Flow Regime
• 12.6. Market Value Forecast, By Therapy, 2017-2031
  • 12.6.1. Bridge-to-Candidacy (BTC)
  • 12.6.2. Bridge-to-Transplant (BTT)
• 12.7. Market Attractiveness, By Therapy
• 12.8. Market Value Forecast, by Location, 2017-2031
  • 12.8.1. Implantable Heart Pump Devices
  • 12.8.2. Extracorporeal Heart Pump Devices
• 12.9. Market Attractiveness, by Location
• 12.10. Market Value Forecast, by End-user, 2017-2031
  • 12.10.1. Hospitals
  • 12.10.2. Ambulatory Surgical Centers
  • 12.10.3. Specialty Clinics
  • 12.10.4. Others
• 12.11. Market Attractiveness, by End-user
• 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.12.1. U.S.
  • 12.12.2. Canada
• 12.13. Market Attractiveness Analysis
  • 12.13.1. By Product
  • 12.13.2. By Flow Regime
  • 12.13.3. By Therapy
  • 12.13.4. By Location
  • 12.13.5. By End-user
  • 12.13.6. By Country

13. Europe Heart Pumps Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Intra-aortic Balloon Pumps
  • 13.2.2. Ventricular Assist Devices
    • 13.2.2.1. Left Ventricle Assist Devices (LVAD)
    • 13.2.2.2. Right Ventricle Assist Devices (RVAD)
    • 13.2.2.3. Biventricular Assist Devices (BVAD)
    • 13.2.2.4. Others
  • 13.2.3. Total Artificial Heart
• 13.3. Market Attractiveness, by Product
• 13.4. Market Value Forecast, by Flow Regime, 2017-2031
  • 13.4.1. Centrifugal Flow Pump (CFP)
  • 13.4.2. Axial Flow Pump (AFP)
  • 13.4.3. Mixed Flow Pump (MFP)
• 13.5. Market Attractiveness, by Flow Regime
• 13.6. Market Value Forecast, By Therapy, 2017-2031
  • 13.6.1. Bridge-to-Candidacy (BTC)
  • 13.6.2. Bridge-to-Transplant (BTT)
• 13.7. Market Attractiveness, By Therapy
• 13.8. Market Value Forecast, by Location, 2017-2031
  • 13.8.1. Implantable Heart Pump Devices
  • 13.8.2. Extracorporeal Heart Pump Devices
• 13.9. Market Attractiveness, by Location
• 13.10. Market Value Forecast, by End-user, 2017-2031
  • 13.10.1. Hospitals
  • 13.10.2. Ambulatory Surgical Centers
  • 13.10.3. Specialty Clinics
  • 13.10.4. Others
• 13.11. Market Attractiveness, by End-user
• 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.12.1. Germany
  • 13.12.2. U.K.
  • 13.12.3. France
  • 13.12.4. Italy
  • 13.12.5. Spain
  • 13.12.6. Rest of Europe
• 13.13. Market Attractiveness Analysis
  • 13.13.1. By Product
  • 13.13.2. By Flow Regime
  • 13.13.3. By Therapy
  • 13.13.4. By Location
  • 13.13.5. By End-user
  • 13.13.6. By Country/Sub-region

14. Asia Pacific Heart Pumps Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2017-2031
  • 14.2.1. Intra-aortic Balloon Pumps
  • 14.2.2. Ventricular Assist Devices
    • 14.2.2.1. Left Ventricle Assist Devices (LVAD)
    • 14.2.2.2. Right Ventricle Assist Devices (RVAD)
    • 14.2.2.3. Biventricular Assist Devices (BVAD)
    • 14.2.2.4. Others
  • 14.2.3. Total Artificial Heart
• 14.3. Market Attractiveness, by Product
• 14.4. Market Value Forecast, by Flow Regime, 2017-2031
  • 14.4.1. Centrifugal Flow Pump (CFP)
  • 14.4.2. Axial Flow Pump (AFP)
  • 14.4.3. Mixed Flow Pump (MFP)
• 14.5. Market Attractiveness, by Flow Regime
• 14.6. Market Value Forecast, By Therapy, 2017-2031
  • 14.6.1. Bridge-to-Candidacy (BTC)
  • 14.6.2. Bridge-to-Transplant (BTT)
• 14.7. Market Attractiveness, By Therapy
• 14.8. Market Value Forecast, by Location, 2017-2031
  • 14.8.1. Implantable Heart Pump Devices
  • 14.8.2. Extracorporeal Heart Pump Devices
• 14.9. Market Attractiveness, by Location
• 14.10. Market Value Forecast, by End-user, 2017-2031
  • 14.10.1. Hospitals
  • 14.10.2. Ambulatory Surgical Centers
  • 14.10.3. Specialty Clinics
  • 14.10.4. Others
• 14.11. Market Attractiveness, by End-user
• 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.12.1. China
  • 14.12.2. Japan
  • 14.12.3. India
  • 14.12.4. Australia & New Zealand
  • 14.12.5. Rest of Asia Pacific
• 14.13. Market Attractiveness Analysis
  • 14.13.1. By Product
  • 14.13.2. By Flow Regime
  • 14.13.3. By Therapy
  • 14.13.4. By Location
  • 14.13.5. By End-user
  • 14.13.6. By Country/Sub-region

15. Latin America Heart Pumps Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product, 2017-2031
  • 15.2.1. Intra-aortic Balloon Pumps
  • 15.2.2. Ventricular Assist Devices
    • 15.2.2.1. Left Ventricle Assist Devices (LVAD)
    • 15.2.2.2. Right Ventricle Assist Devices (RVAD)
    • 15.2.2.3. Biventricular Assist Devices (BVAD)
    • 15.2.2.4. Others
  • 15.2.3. Total Artificial Heart
• 15.3. Market Attractiveness, by Product
• 15.4. Market Value Forecast, by Flow Regime, 2017-2031
  • 15.4.1. Centrifugal Flow Pump (CFP)
  • 15.4.2. Axial Flow Pump (AFP)
  • 15.4.3. Mixed Flow Pump (MFP)
• 15.5. Market Attractiveness, by Flow Regime
• 15.6. Market Value Forecast, By Therapy, 2017-2031
  • 15.6.1. Bridge-to-Candidacy (BTC)
  • 15.6.2. Bridge-to-Transplant (BTT)
• 15.7. Market Attractiveness, By Therapy
• 15.8. Market Value Forecast, by Location, 2017-2031
  • 15.8.1. Implantable Heart Pump Devices
  • 15.8.2. Extracorporeal Heart Pump Devices
• 15.9. Market Attractiveness, by Location
• 15.10. Market Value Forecast, by End-user, 2017-2031
  • 15.10.1. Hospitals
  • 15.10.2. Ambulatory Surgical Centers
  • 15.10.3. Specialty Clinics
  • 15.10.4. Others
• 15.11. Market Attractiveness, by End-user
• 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 15.12.1. Brazil
  • 15.12.2. Mexico
  • 15.12.3. Rest of Latin America
• 15.13. Market Attractiveness Analysis
  • 15.13.1. By Product
  • 15.13.2. By Flow Regime
  • 15.13.3. By Therapy
  • 15.13.4. By Location
  • 15.13.5. By End-user
  • 15.13.6. By Country/Sub-region

16. Middle East & Africa Heart Pumps Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast, by Product, 2017-2031
  • 16.2.1. Intra-aortic Balloon Pumps
  • 16.2.2. Ventricular Assist Devices
    • 16.2.2.1. Left Ventricle Assist Devices (LVAD)
    • 16.2.2.2. Right Ventricle Assist Devices (RVAD)
    • 16.2.2.3. Biventricular Assist Devices (BVAD)
    • 16.2.2.4. Others
  • 16.2.3. Total Artificial Heart
• 16.3. Market Attractiveness, by Product
• 16.4. Market Value Forecast, by Flow Regime, 2017-2031
  • 16.4.1. Centrifugal Flow Pump (CFP)
  • 16.4.2. Axial Flow Pump (AFP)
  • 16.4.3. Mixed Flow Pump (MFP)
• 16.5. Market Attractiveness, by Flow Regime
• 16.6. Market Value Forecast, By Therapy, 2017-2031
  • 16.6.1. Bridge-to-Candidacy (BTC)
  • 16.6.2. Bridge-to-Transplant (BTT)
• 16.7. Market Attractiveness, By Therapy
• 16.8. Market Value Forecast, by Location, 2017-2031
  • 16.8.1. Implantable Heart Pump Devices
  • 16.8.2. Extracorporeal Heart Pump Devices
• 16.9. Market Attractiveness, by Location
• 16.10. Market Value Forecast, by End-user, 2017-2031
  • 16.10.1. Hospitals
  • 16.10.2. Ambulatory Surgical Centers
  • 16.10.3. Specialty Clinics
  • 16.10.4. Others
• 16.11. Market Attractiveness, by End-user
• 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 16.12.1. GCC Countries
  • 16.12.2. South Africa
  • 16.12.3. Rest of Middle East & Africa
• 16.13. Market Attractiveness Analysis
  • 16.13.1. By Product
  • 16.13.2. By Flow Regime
  • 16.13.3. By Therapy
  • 16.13.4. By Location
  • 16.13.5. By End-user
  • 16.13.6. By Country/Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
• 17.2. Market Share Analysis, by Company (2022)
• 17.3. Company Profiles
  • 17.3.1. SynCardia Systems, LLC
    • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.1.2. Product Portfolio
    • 17.3.1.3. Financial Overview
    • 17.3.1.4. SWOT Analysis
    • 17.3.1.5. Strategic Overview
  • 17.3.2. Berlin Heart GmbH
    • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.2.2. Product Portfolio
    • 17.3.2.3. Financial Overview
    • 17.3.2.4. SWOT Analysis
    • 17.3.2.5. Strategic Overview
  • 17.3.3. Jarvik Heart Inc.
    • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.3.2. Product Portfolio
    • 17.3.3.3. Financial Overview
    • 17.3.3.4. SWOT Analysis
    • 17.3.3.5. Strategic Overview
  • 17.3.4. Calon Cardio-Technology Ltd.
    • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.4.2. Product Portfolio
    • 17.3.4.3. Financial Overview
    • 17.3.4.4. SWOT Analysis
    • 17.3.4.5. Strategic Overview
  • 17.3.5. Teleflex Incorporated
    • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.5.2. Product Portfolio
    • 17.3.5.3. Financial Overview
    • 17.3.5.4. SWOT Analysis
    • 17.3.5.5. Strategic Overview
  • 17.3.6. Abbott Laboratories
    • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.6.2. Product Portfolio
    • 17.3.6.3. Financial Overview
    • 17.3.6.4. SWOT Analysis
    • 17.3.6.5. Strategic Overview
  • 17.3.7. Medtronic plc
    • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.7.2. Product Portfolio
    • 17.3.7.3. Financial Overview
    • 17.3.7.4. SWOT Analysis
    • 17.3.7.5. Strategic Overview